Loading…
Pelage Pharmaceuticals is developing PP405, a topical small molecule treatment that reactivates dormant hair follicle stem cells to regrow hair. The company's approach targets a metabolic switch in hair follicles, offering a non-hormonal, non-invasive solution for all genders and hair types.
We haven’t found Pelage Pharmaceuticals in the AI answers we’ve checked.
